UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The New England journal of medicine, ISSN 0028-4793, 03/2018, Volume 378, Issue 9, pp. 797 - 808
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Recurrence | Double-Blind Method | Fungemia - etiology | Humans | Middle Aged | Renal Replacement Therapy | Shock, Septic - complications | Hydrocortisone - therapeutic use | Male | Survival Rate | Treatment Outcome | Shock, Septic - mortality | Respiration, Artificial | Shock, Septic - therapy | Hydrocortisone - adverse effects | Anti-Inflammatory Agents - adverse effects | Shock, Septic - drug therapy | Anti-Inflammatory Agents - therapeutic use | Bacteremia - etiology | Female | Aged | Chemotherapy, Adjuvant | Infusions, Intravenous | APACHE | Septic shock | Dosage and administration | Corticosteroids | Safety and security measures | Diagnosis | Health care | Shock | Ventilators | Intensive care | Statistical analysis | Glucocorticoids | Mortality | Preventive medicine | Hydrocortisone | Blood transfusion | Bacteremia | Design | Hospitals | Fungemia | Pharmacy | Ventilation | Sepsis | Clinical medicine | Renal replacement therapy | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 11/2012, Volume 367, Issue 20, pp. 1901 - 1911
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Intensive Care Units | Resuscitation - methods | Hospital Mortality | Humans | Middle Aged | Male | Creatinine - urine | Fluid Therapy - adverse effects | Sodium Chloride - therapeutic use | Critical Illness - mortality | Fluid Therapy - methods | Intention to Treat Analysis | Creatinine - blood | Critical Illness - therapy | Hydroxyethyl Starch Derivatives - therapeutic use | Adult | Critical Care | Female | Aged | Kidney Diseases - etiology | Hydroxyethyl Starch Derivatives - adverse effects | Care and treatment | Usage | Kidney failure | Critically ill | Patient outcomes | Physiologic salines | Health aspects | Risk factors | Resuscitation | Methods | Ethics | Intensive care | Fluids | Renal function | Starch | Mortality | Renal failure | Clinical trials | Hydroxyethyl starch | Sodium chloride | Patients | Molecular weight | Index Medicus | Abridged Index Medicus
Journal Article
Molecular and Cellular Biology, ISSN 0270-7306, 11/2009, Volume 29, Issue 21, pp. 5872 - 5888
Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Gene Expression Regulation, Enzymologic - drug effects | Humans | Guanidines - pharmacology | Nicotinamide Phosphoribosyltransferase - antagonists & inhibitors | Niacin - pharmacology | Niacin - administration & dosage | Nicotinamide Phosphoribosyltransferase - metabolism | NAD - biosynthesis | Cell Death - drug effects | Cyanides - therapeutic use | Gene Expression Regulation, Neoplastic - drug effects | Phosphorylation - drug effects | Ribose - metabolism | Cyanides - pharmacology | Models, Molecular | Neoplasms - enzymology | Nicotinamide Phosphoribosyltransferase - deficiency | Neoplasms - drug therapy | Xenograft Model Antitumor Assays | Nicotinamide Phosphoribosyltransferase - genetics | Animals | Substrate Specificity - drug effects | Models, Biological | Cell Line, Tumor | Mice | Guanidines - therapeutic use | Drug Resistance, Neoplasm - drug effects | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 09/2016, Volume 375, Issue 10, pp. 919 - 931
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Continuous Positive Airway Pressure | Sleep Apnea, Obstructive - therapy | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Treatment Outcome | Hospitalization | Sleep Apnea, Obstructive - etiology | Cerebrovascular Disorders - complications | Coronary Artery Disease - complications | Intention to Treat Analysis | Cardiovascular Diseases - mortality | Female | Aged | Prevention | Usage | Sleep apnea syndromes | Diagnosis | Cardiovascular diseases | Continuous positive airway pressure | Myocardial infarction | Respiratory therapy | Cerebral infarction | Stroke | Transient ischemic attack | Daytime | Clinical trials | Cardiovascular disease | Sleep apnea | Angina | Quality of life | Respiratory tract | Sleep disorders | Airway management | Sleep | Apnea | Mood | Ischemia | Heart diseases | Sleep and wakefulness | Index Medicus | Abridged Index Medicus
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 09/2013, Volume 310, Issue 9, pp. 918 - 929
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Public health. Hygiene-occupational medicine | Public health. Hygiene | Biological and medical sciences | General aspects | Medical sciences | Epidemiology | Medication Adherence - statistics & numerical data | Simvastatin - administration & dosage | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Risk Factors | Cholesterol, LDL - drug effects | Male | Treatment Outcome | Hydrochlorothiazide - administration & dosage | Antihypertensive Agents - adverse effects | Aspirin - administration & dosage | Anticholesteremic Agents - administration & dosage | Platelet Aggregation Inhibitors - administration & dosage | Cholesterol, LDL - blood | Female | Aged | Blood Pressure - drug effects | Atenolol - administration & dosage | Drug Combinations | Lisinopril - administration & dosage | Clinical trials | Cardiovascular disease | Blood pressure | Patients | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 05/2018, Volume 378, Issue 18, pp. 1744 - 1745
Journal Article
The New England journal of medicine, ISSN 0028-4793, 10/2010, Volume 363, Issue 15, pp. 1410 - 1418
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Hypoglycemic Agents - therapeutic use | Follow-Up Studies | Vascular Diseases - etiology | Humans | Middle Aged | Risk Factors | Proportional Hazards Models | Male | Vascular Diseases - epidemiology | Diabetes Mellitus, Type 2 - blood | Gliclazide - therapeutic use | Diabetes Mellitus, Type 2 - mortality | Cardiovascular Diseases - mortality | Hypoglycemia - complications | Microvessels | Female | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Gliclazide - adverse effects | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Outcome and process assessment (Health Care) | Complications and side effects | Blood circulation disorders | Hypoglycemia | Risk factors | Diabetes | Glucose | Acute coronary syndromes | Mortality | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 10/2014, Volume 371, Issue 15, pp. 1392 - 1406
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | General aspects | Diabetes. Impaired glucose tolerance | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Glycated Hemoglobin A - analysis | Follow-Up Studies | Humans | Middle Aged | Risk Factors | Indapamide - therapeutic use | Blood Glucose | Hypertension - drug therapy | Male | Gliclazide - administration & dosage | Antihypertensive Agents - therapeutic use | Diabetes Mellitus, Type 2 - blood | Hypoglycemic Agents - administration & dosage | Diabetes Mellitus, Type 2 - mortality | Hypertension - complications | Female | Diabetes Mellitus, Type 2 - drug therapy | Perindopril - therapeutic use | Diabetes Mellitus, Type 2 - complications | Drug Combinations | Type 2 diabetes | Care and treatment | Blood pressure | Research | Patient outcomes | Indapamide | Diabetes mellitus | Mortality | Cardiovascular disease | Glucose | Confidence intervals | Ratios | Vascular diseases | Hemoglobin | Death | Diabetes | Kidney diseases | Diabetes mellitus (non-insulin dependent) | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 03/2017, Volume 376, Issue 12, pp. 1111 - 1120
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Disability Evaluation | Analgesics - therapeutic use | Pregabalin - administration & dosage | Pregabalin - adverse effects | Back Pain - classification | Double-Blind Method | Pregabalin - therapeutic use | Humans | Middle Aged | Sciatica - classification | Dizziness - chemically induced | Analgesics - administration & dosage | Male | Sciatica - drug therapy | Treatment Failure | Quality of Life | Adult | Female | Aged | Pain Measurement | Analgesics - adverse effects | Complications and side effects | Treatment outcome | Patient outcomes | Placebos | Dosage and administration | Pregabalin | Drug therapy | Comparative analysis | Sciatica | Pain | Neurons | Pain management | Clinical trials | Neuropathy | Patients | Leg | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article